 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
EXACT SCIENCES CO, (EXAS) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
EXACT Sciences Corporation, an applied genomics company, engages in the development and commercialization of deoxyribonucleic acid (DNA)-based tests for the early detection of cancer. The company offers PreGen-Plus through LabCorp, a DNA-based test used for screening for colorectal cancer. PreGen-Plus includes technologies that isolate and analyze the trace amounts of human DNA that are shed into stool every day from the exfoliation of cells that line the colon. It looks for specific mutations and other abnormalities in that DNA associated with colorectal cancer. The companys strategic partners include LabCorp and Laboratory Corporation of America Holdings. EXACT Sciences Corporation was founded in 1995 and is headquartered in Marlborough, Massachusetts.
|
|
|
|
|
